[HTML][HTML] Antiviral drugs and their roles in the treatment of coronavirus infection

R Alsafi, S Alghamdi, M Asif - Antiviral Drugs-Intervention …, 2022 - intechopen.com
Viruses are the major pathogenic agents that cause various diseases. Antiviral drugs are
used for the treatment of viral infections. Emergent advances of antiviral drugs are focused …

An update on emerging therapeutics to combat COVID‐19

NN Shah, SU Nabi, MA Rather… - Basic & clinical …, 2021 - Wiley Online Library
Background The COVID‐19 pandemic has demanded effective therapeutic protocol from
researchers and clinicians across the world. Currently, a large amount of primary data have …

Current challenges for the effective management of the COVID-19 pandemic

V Sinha, S Saxena, SK Pandey, S Dwivedi… - … Therapeutics–Volume II …, 2022 - Springer
Introduction: Within a short period, the coronavirus disease (COVID-19) caused by severe
acute respiratory syndrome coronavirus (SARS-CoV-2) spread all over the globe and …

[HTML][HTML] Emerging pharmaceutical treatments of novel COVID-19: a review

A Hussain, J Kaler, AK Dubey - Cureus, 2020 - ncbi.nlm.nih.gov
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …

[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

MS Mirtaleb, AH Mirtaleb, H Nosrati… - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …

Current scenario and future prospect in the management of COVID-19

P Borah, PK Deb, S Deka… - Current Medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …

Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID‐19) and the rationale for their utilization: a review

RA Giovane, S Rezai, E Cleland… - Reviews in Medical …, 2020 - Wiley Online Library
SARS‐CoV‐2 has caused a pandemic which is putting strain on the health‐care system and
global economy. There is much pressure to develop both preventative and curative …

Promising repurposed antiviral molecules to combat SARS-CoV-2: A review

Y Ratan, A Rajput, V Jain, DK Mishra… - Current …, 2023 - ingentaconnect.com
COVID-19, an extremely transmissible and pathogenic viral disease, triggered a global
pandemic that claimed lives worldwide. To date, there is no clear and fully effective …

SARS-CoV-2: An update on potential antivirals in light of SARS-CoV antiviral drug discoveries

HA Elshabrawy - Vaccines, 2020 - mdpi.com
Coronaviruses (CoVs) are a group of RNA viruses that are associated with different
diseases in animals, birds, and humans. Human CoVs (HCoVs) have long been known to …

A focus on the nowadays potential antiviral strategies in early phase of coronavirus disease 2019 (Covid-19): A narrative review

C Monari, V Gentile, C Camaioni, G Marino, N Coppola… - Life, 2020 - mdpi.com
Background: The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic …